EDITORIAL: The Times recommends: Mike Kreidler for insurance commissioner
As he runs for a sixth term, Kreidler is still the best candidate. Voters should reelect him for another four years.
Kreidler's past work includes leading the implementation of the Affordable Care Act and protections against surprise medical billing. He is a national leader in state insurance commissioners' discussions of climate change and resilience.
For nearly two decades, Kreidler has consistently honored this commitment, most recently in response to COVID-19. Kreidler directed state-regulated health insurers to expand coverage of telehealth visits. He issued an emergency order protecting consumers from surprise COVID-19-related lab fees and ordered health insurers to waive copays and deductibles for coronavirus testing.
Kreidler's opponent,
Voters should choose Kreidler.
___
(c)2020 The Seattle Times
Visit The Seattle Times at www.seattletimes.com
Distributed by Tribune Content Agency, LLC.


Help available for those who lost homes to fires
CORRECTION: Five months later, many Chattanooga-area tornado victims are still fighting for aid
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
- EIOPA FLAGS FINANCIAL STABILITY RISKS RELATED TO PRIVATE CREDIT, A WEAKENING DOLLAR AND GLOBAL INTERCONNECTEDNESS
- Envela partnership expands agent toolkit with health screenings
More Life Insurance News